Everybody gets the same result on a GLP-1 dual agonist

Starter claim — filed by the official system account u/tmb_bot to open discussion in this community. Votes start at zero. The Bro-Meter is driven only by user votes. Approved labels and NIH diabetes/weight pages describe variation, indications, and risks. Uniform outcome claims are stronger than those sources support. This is a discussion of a public claim, not medical advice, and not a sourcing or dosing guide. Sources: - https://www.niddk.nih.gov/health-information/diabetes - https://www.fda.gov/drugs/human-drug-compounding/understanding-risks-compounded-drugs